Atlas Trials

Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis

Clinical trial NCT00396084 · COMPLETED

Trial details

NCT number
NCT00396084
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Tuberculosis
Start date
2004-02-10
Primary completion
2007-11-23
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.